95
Views
19
CrossRef citations to date
0
Altmetric
Original Research

10H-3,6-Diazaphenothiazine induces G2/M phase cell cycle arrest and caspase-dependent apoptosis and inhibits cell invasion of A2780 ovarian carcinoma cells through the regulation of NF-κB and (BIRC6-XIAP) complexes

, , , , , , , , & show all
Pages 3045-3063 | Published online: 24 Oct 2017

References

  • TorreLSiegelRJemalAGlobal Cancer Facts and Figures3rd edAtlanta, GA, USAAmerican Cancer Society2015
  • LeeSWhangIWanQProfiles of teleost DNA fragmentation factor alpha and beta from rock bream (Oplegnathus fasciatus): molecular characterization and genomic structure and gene expression in immune stressGenes Genom201638 193 204
  • BaghbaniFMoztarzadehFBypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodropletsCol Sur B Biointerfaces2017153 132 140
  • RzepeckaIKSzafronLMStysAPrognosis of patients with BRCA1-associated ovarian carcinomas depends on TP53 accumulation status in tumor cellsGynecol Oncol2017144 369 37627939982
  • RossingMAWicklundKGCushing-HaugenKLPredictive value of symptoms for early detection of ovarian cancerJ Natl Cancer Inst2010102 222 22920110551
  • OreRMBaldwinLWoolumDSymptoms relevant to surveillance for ovarian cancerDiagnostics20177 18
  • UrbanNHawleySJanesHIdentifying post-menopausal women at elevated risk for epithelial ovarian cancerGynecol Oncol2015139 253 26026343159
  • LeungACYCookLSSwenertonKTea, coffee, and caffeinated beverage consumption and risk of epithelial ovarian cancersCancer Epid201645 119 125
  • BurghausSFaschingPAHaberleLGenetic risk factors for ovarian cancer and their role for endometriosis riskGynecol Oncol2017145 142 14728214017
  • ChiyodaTHartPCEckertMALoss of BRCA1 in the cells of origin of ovarian cancer induces glycolysis: a window of opportunity for ovarian cancer chemopreventionCancer Prev Res201710 255 266
  • WangRKangYLohrCVReciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancerCancer Lett2016381 341 34827539959
  • LamersFSchildLKosterJTargeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expressionEur J Cancer201248 763 77122088485
  • ChaudharyAKYadavNBhatTAA potential role of X-linked inhibitor of apoptosis protein in mitochondrial membrane permeabilization and its implication in cancer therapyDrug Dis Today201621 38 47
  • TurnerTBBuchsbaumDJStraughnJMJrOvarian cancer and the immune system – the role of targeted therapiesGynecol Oncol2016142 349 35627174875
  • LiYJiangYYiYApplication of auricular acupoints therapy in relieving the gastrointestinal side effects induced by chemotherapy: an integrative reviewChinese Nurs Res20163 58 61
  • PlutaKMorak-MłodawskaBJeleńMRecent progress in biological activities of synthesized phenothiazinesEur J Med Chem201148 3179 3189
  • ZimeckiMArtymJKociębaMThe immunosuppressive activities of newly synthesized azaphenothiazines in human and mouse modelsCell Mol Biol Lett200915 622 635
  • PlutaKJeleńMMorak-MłodawskaBAnticancer activity of newly synthesized azaphenothiazines from NCI’s anticancer screening bankPharmacol Rep201062 319 33220508288
  • Morak-MłodawskaBPlutaKLatochaMSynthesis, spectroscopic characterization, and anticancer activity of new 10-substituted 1,6-diazaphenothiazinesMed Chem Res201625 2425 243327818603
  • Morak-MłodawskaBPlutaKLatochaMSuwińkaKJeleńMKuśmierzD3,6-Diazaphenothiazines as potential lead molecules – synthesis, characterization and anticancer activityJ Enzyme Inhib Med Chem201631 1512 151926950280
  • KastrinskyDBSangodkarJZawareNReengineered tricyclic anticancer agentsBioorg Med Chem201523 6528 653426372073
  • PrinzHRidderAKVogelKN-heterocyclic (4-phenylpiperazin-1-yl)methanones derived from phenoxazine and phenothiazine as highly potent inhibitors of tubulin polymerizationJ Med Chem201760 749 76628045256
  • BisiAMeliMGobbiSMultidrug resistance reverting activity and antitumor profile of new phenothiazine derivativesBioorg Med Chem200816 6474 648218522868
  • KimJSHeLLemastersJJMitochondrial permeability transition: a common pathway to necrosis and apoptosisBiochem Biophys Res Commun2003304 463 47012729580
  • SappanimuthuTKilambiNSundaramSAntimicrobial activity of new dumbbell-shaped phenothiazine cinnamidesRes Chem Intermed201743 2401 2414
  • LundRJHuhtinenKSalmiJDNA methylation and transcriptome changes associated with cisplatin resistance in ovarian cancerSci Rep20177 146928473707
  • XiaoMCaiJCaiLQLet-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repairJ Ovarian Res201710 24 3628376831
  • PaiSGCarneiroBAMotaJMWnt/beta-catenin pathway: modulating anticancer immune responseJ Hematol Oncol201710 101 11128476164
  • DeshmukSKSrivastavaSKZubairHResistin potentiates chemoresistance and sternness of breast cancer cells: implications for racially disparate therapeutic outcomesCancer Lett2017396 21 2928302531
  • OoiKKAngKPAbdahMAPhosphanegold(I) thiolates, Ph3PAu[SC(O-R)=NC6H4Me-4] for R = Me, Et and iPr, induce apoptosis, cell cycle arrest and inhibit cell invasion of HT-29 colon cancer cells through modulation of the nuclear factor-κB activation pathway and ubiquitinationJ Biol Inorg Chem201520 855 87326003312
  • ZamaraevAVKopeinaGSProkhorovaEAPost-translational modification of caspases: the other side of apoptosis regulationTrends Cell Biol201727 322 33928188028
  • FlachRJRQinHZhangLLoss of mitogen-activated protein kinase phosphatase-1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor A (DFFA)-like effector C (CIDEC)/fat-specific protein 27J Biol Chem2011286 22195 2220221521693
  • DengZGaoPYuLLRuthenium complexes with phenylterpyridine derivatives target cell membrane and trigger death receptors-mediated apoptosis in cancer cellsBiomaterials2017129 111 12628340357
  • Atkin-SmithGKPoonIKHDisassembly of the dying: mechanisms and functionsTrends Cell Biol201727 151 16227647018
  • HolmgrenALuJThioredoxin and thioredoxin reductase: current research with special reference to human diseaseBiochem Biophys Res Commun2010396 120 12420494123
  • LiuYDuanDYaoJDithiaarsanes induce oxidative stress-mediated apoptosis in HL-60 cells by selectively targeting thioredoxin reductaseJ Med Chem201457 5203 521124867309
  • WeiJZhangLRenLHEndosulfan induces cell dysfunction through cycle arrest resulting from DNA damage and DNA damage response signaling pathwaysSci Total Environ2017589 97 10628273598
  • AlmadaMFonsecaBMAmaralCAnandamide oxidative metabolism-induced endoplasmic reticulum stress and apoptosisApoptosis201722 816 82628220271
  • SunRWYCheCMThe anti-cancer properties of gold (III) compounds with dianionic porphyrin and tetradentate ligandsCoord Chem Rev2009253 1682 1691
  • Redza-DutordoirMAverill-BatesDAActivation of apoptosis signaling pathways by reactive oxygen speciesBiochim Biophys Acta20161863 2977 299227646922
  • García-SáezAJMingarroIPérez-PayáEMembrane-insertion fragments of Bcl-xL, Bax, and BidBiochemistry200443 10930 1094315323553
  • HuertaSHeinzerlingJHAuguiano-HernandezYMModification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFκB, IAPs, Smac/DIABLO, and AIFJ Surg Res2007142 184 19417603079
  • ReedJCApoptosis-targeted therapies for cancerCancer Cell20033 17 2212559172
  • Attaran-BandarabadiFAbhariBANeishabouriSHIntegrity of XIAP is essential for effective activity recovery of apoptosome and its downstream caspases by Smac/DiabloInt J Biol Marc2017101 283 289
  • ShakeriRKheirollahiADavoodiJApaf-1: regulation and function in cell deathBiochimie2017135 111 12528192157
  • LinderMTschernigTVasculogenic mimicry: possible role of effector caspase-3, caspase-6 and caspase-7Ann Anat2016204 114 11726704356
  • DavoodiJGhahremaniMHEs-haghiANeuronal apoptosis inhibitory protein, NAIP, is an inhibitor of procaspase-9Int J Biochem Cell Biol201042 958 96420171302
  • Kaparakis-LiaskosMThe intracellular location mechanisms and outcomes of NOD1 signallingCytokine201574 207 21225801093
  • KutikhinAGRole of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiologyHuman Immunol201172 955 96821745515
  • YinDWoodruffMZhangYMorphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-κB pathwaysJ Neuroimmunol2006174 101 10716529824
  • ParkYHJeongMSParkHHFormation of the death domain complex between FADD and RIP1 proteins in vitroBiochim Biophys Acta20131834 292 30022922561
  • ShuklaKSharmaAKWillRMicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancerMol Oncol20159 1106 111925732226
  • ParkYHJeongMSJangSBDeath domain complex of the TNFR-1, TRADD, and RIP1 proteins for death-inducing signalingBiochem Biophys Res Commun2014443 1155 116124361886
  • VeresovVGDavidovskiiAIActivation of Bax by joint action of tBid and mitochondrial outer membrane: Monte Carlo simulationsEur Biophys J200938 941 96019466402
  • CheckerRPatwardhanRSSharmaDPlumbagin, a vitamin K3 analogue, abrogates lipopolysaccharide-induced oxidative stress, inflammation and endotoxic shock via NF-kappa B suppressionInflammation201437 542 55424234154
  • AhmadABanerjeeSWangZPlumbagin-induced apoptosis of human breast cancer cells is mediated by inactivation of NF-kappaB and Bcl-2J Cell Biochem2008105 1461 147118980240
  • BaoWZhuFDuanYHtrA1 resensitizes multidrug-resistant hepatocellular carcinoma cells by targeting XIAPBiomed Pharmacother201570 97 10225776486
  • McCubreyJALertpiriyapongKFitzgeraldTLRoles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasisAdv Biol Regul201763 32 4827776972
  • XuLZhouRYuanLIGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasisCancer Lett2017393 76 8528223169
  • WernerHSarfsteinRTranscriptional and epigenetic control of IGF1R gene expression: implications in metabolism and cancerGrowth Horm IGF Res201424 112 11824863809
  • TiwariVKamranMZRanjanAAkt1/NFκB signaling pathway activation by a small molecule DMA confers radioprotection to intestinal epithelium in xenograft modelFree Radic Biol Med2017108 564 57428435051
  • SabbineniHAlwhaibiAGocAGenetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasionEur J Pharmacol2015764 208 21426148825
  • ZhouWFuXLiuJRNAi knockdown of the Akt1 gene increases the chemosensitivity of gastric cancer cells to cisplatin both in vitro and in vivoRegul Peptides2012176 13 21
  • YangXLiuSKharbandaSAKT1 induces caspase-mediated cleavage of the CDK inhibitor p27Kip1 during cell cycle progression in leukemia cells transformed by FLT3-ITDLeukemia Res201236 205 21122142798
  • LopesMRMachado-NetoJATrainaFDifferential profile of CDKN1A and TP53 expressions in bone marrow mesenchymal stromal cells from myeloid neoplasmsRev Bras Hematol Hemoter201638 368 37027863768
  • RöhrsSKutznerNVladAChronological expression of Wnt target genes CCND1, MYC, CDKN1A, TFRC, PLF1 and Ramp3Cell Biol Int200933 501 50819353769
  • SuhailTVSinghPMannaTKSuppression of centrosome protein TACC3 induces G1 arrest and cell death through activation of p38–p53–p21 stress signaling pathwayEur J Cell Biol201594 90 10025613365
  • NakagawaJMatsuokaMSuppression of zinc-induced p53 phosphorylation and p21 expression by wortmannin in A549 human pulmonary epithelial cellsEnviron Toxicol Pharmacol200826 109 11221783897
  • LiDDaiCZhouYEffect of GADD45a on olaquindox-induced apoptosis in human hepatoma G2 cells: involvement of mitochondrial dysfunctionEnv Toxicol Pharmacol201646 140 14627458702
  • GongHJCaoYHanGp3/microRNA-374b/AKT1 regulates colorectal cancer cell apoptosis in response to DNA damageInt J Oncol201750 1785 179128339062
  • AmableLCisplatin resistance and opportunities for precision medicinePharmacol Res2016106 27 3626804248